The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Aug. 26, 2022
Applicant:
The Wistar Institute, Philadelphia, PA (US);
Inventors:
Troy E. Messick, Upper Darby, PA (US);
Paul M. Lieberman, Wynnewood, PA (US);
Garry R. Smith, Elverson, PA (US);
Arlindo L. Castelhano, New York, NY (US);
Assignee:
The Wistar Institute, Philadelphia, PA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/12 (2006.01); A61K 31/404 (2006.01); A61K 45/06 (2006.01); A61P 25/28 (2006.01); A61P 31/22 (2006.01); A61P 35/02 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 405/12 (2013.01); A61K 31/404 (2013.01); A61P 25/28 (2018.01); A61P 31/22 (2018.01); A61P 35/02 (2018.01); A61K 9/0053 (2013.01); A61K 45/06 (2013.01); C07B 2200/13 (2013.01);
Abstract
The invention relates, in certain aspects, to developable forms of certain compounds that are useful to treat and/or prevent EBV infection and related conditions in a subject. The invention further provides EBNA1 inhibitors, and/or pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection and/or lytic EBV infection.